Stock Track | Replimune Group Soars 5.20% on Multiple Analyst Upgrades and Price Target Hikes

Stock Track

Oct 21, 2025

Replimune Group Inc (REPL) saw its stock soar 5.20% in Tuesday's pre-market trading session following a series of positive analyst actions. The biotechnology company received multiple upgrades and price target increases from prominent Wall Street firms, signaling growing confidence in its prospects.

JP Morgan raised its rating on Replimune from Underweight to Neutral, indicating a more favorable outlook on the company. Simultaneously, Piper Sandler upgraded the stock to Overweight from Neutral and significantly boosted its price target to $13 from $8, suggesting substantial upside potential. Jefferies also expressed optimism by raising its price target for Replimune to $13 from $8.

These upgrades and target price hikes reflect a growing positive sentiment among analysts regarding Replimune's business outlook and potential. While specific reasons for the improved outlook were not detailed in the available news, such actions often follow positive developments in a company's pipeline, financial performance, or market positioning. Investors responded enthusiastically to these analyst actions, driving the stock's pre-market surge.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1148531766"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1148531766\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1148531766?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-21 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148531766","market":"us","top_or_hot":-1,"title":"Stock Track | Replimune Group Soars 5.20% on Multiple Analyst Upgrades and Price Target Hikes","media":"Stock Track","content":"<p>Replimune Group Inc (REPL) saw its stock soar 5.20% in Tuesday's pre-market trading session following a series of positive analyst actions. The biotechnology company received multiple upgrades and price target increases from prominent Wall Street firms, signaling growing confidence in its prospects.</p>\n\n<p>JP Morgan raised its rating on Replimune from Underweight to Neutral, indicating a more favorable outlook on the company. Simultaneously, Piper Sandler upgraded the stock to Overweight from Neutral and significantly boosted its price target to $13 from $8, suggesting substantial upside potential. Jefferies also expressed optimism by raising its price target for Replimune to $13 from $8.</p>\n\n<p>These upgrades and target price hikes reflect a growing positive sentiment among analysts regarding Replimune's business outlook and potential. While specific reasons for the improved outlook were not detailed in the available news, such actions often follow positive developments in a company's pipeline, financial performance, or market positioning. Investors responded enthusiastically to these analyst actions, driving the stock's pre-market surge.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Replimune Group Soars 5.20% on Multiple Analyst Upgrades and Price Target Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Replimune Group Soars 5.20% on Multiple Analyst Upgrades and Price Target Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-21 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Replimune Group Inc (REPL) saw its stock soar 5.20% in Tuesday's pre-market trading session following a series of positive analyst actions. The biotechnology company received multiple upgrades and price target increases from prominent Wall Street firms, signaling growing confidence in its prospects.</p>\n\n<p>JP Morgan raised its rating on Replimune from Underweight to Neutral, indicating a more favorable outlook on the company. Simultaneously, Piper Sandler upgraded the stock to Overweight from Neutral and significantly boosted its price target to $13 from $8, suggesting substantial upside potential. Jefferies also expressed optimism by raising its price target for Replimune to $13 from $8.</p>\n\n<p>These upgrades and target price hikes reflect a growing positive sentiment among analysts regarding Replimune's business outlook and potential. While specific reasons for the improved outlook were not detailed in the available news, such actions often follow positive developments in a company's pipeline, financial performance, or market positioning. Investors responded enthusiastically to these analyst actions, driving the stock's pre-market surge.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REPL","symbol_name":"Replimune Group Inc.","start_time":0,"source_url":"","article_id":"1148531766","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148531766","pubTimestamp":1761053572,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Replimune Group Inc (REPL) saw its stock soar 5.20% in Tuesday's pre-market trading session following a series of positive analyst actions. The biotechnology company received multiple upgrades and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"REPL":"Replimune Group Inc."},"translate_title":"股票追踪|Replimune Group因多位分析师上调评级和目标价上调而飙升5.20%","themeId":"26c657bd6894c690b20c7751c141e52e","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REPL":1},"content_text":"Replimune Group Inc (REPL) saw its stock soar 5.20% in Tuesday's pre-market trading session following a series of positive analyst actions. The biotechnology company received multiple upgrades and price target increases from prominent Wall Street firms, signaling growing confidence in its prospects.\nJP Morgan raised its rating on Replimune from Underweight to Neutral, indicating a more favorable outlook on the company. Simultaneously, Piper Sandler upgraded the stock to Overweight from Neutral and significantly boosted its price target to $13 from $8, suggesting substantial upside potential. Jefferies also expressed optimism by raising its price target for Replimune to $13 from $8.\nThese upgrades and target price hikes reflect a growing positive sentiment among analysts regarding Replimune's business outlook and potential. While specific reasons for the improved outlook were not detailed in the available news, such actions often follow positive developments in a company's pipeline, financial performance, or market positioning. Investors responded enthusiastically to these analyst actions, driving the stock's pre-market surge.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}